Publication
India's Panacea Biotec to produce 100 million Sputnik V doses annually
Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia’s Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
RDIF did not say when production would begin, Reuters reports.
Comments